Hologic (HOLX) is a publicly traded Healthcare sector company. As of May 20, 2026, HOLX trades at $76.01 with a market cap of $16.97B and a P/E ratio of 31.41. HOLX moved +0.00% today. Year to date, HOLX is +2.52%; over the trailing twelve months it is +23.21%. Its 52-week range spans $51.90 to $84.39. Analyst consensus is hold with an average price target of $79.00. Rallies surfaces HOLX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
HOLX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. HOLX recently traded at $76.01. Market cap is $16.97B. P/E ratio is 31.41. Revenue is $4.13B.
| Metric | Value |
|---|---|
| Price | $76.01 |
| Market Cap | $16.97B |
| P/E Ratio | 31.41 |
| EPS | $2.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $84.39 |
| 52-Week Low | $51.90 |
| Volume | 102.03M |
| Avg Volume | 0 |
| Revenue (TTM) | $4.13B |
| Net Income | $543.80M |
| Gross Margin | 51.47% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $4.10B | $565.70M | $2.50 |
| 2023 | $4.03B | $456.00M | $1.85 |
| 2022 | $4.86B | $1.30B | $5.18 |
| 2021 | $5.63B | $1.87B | $7.28 |
42 analysts cover HOLX: 0 strong buy, 18 buy, 23 hold, 1 sell, 0 strong sell. Consensus rating is hold. Average price target: $79.00.